Outside of RCC, lower ITGAL expression in non-small-cell lung cancer was associated with worse prognosis, with higher immune infiltration in malignant tissues.32 Similar trends were seen in patients with melanoma.33 This evidence concerns the gene ITGAL and renal cell carcinoma.